Oncternal Therapeutics Inc. buy blaugold
Start price
12.12.21
/
50%
€2.61
Target price
12.12.22
-
Performance (%)
-18.44%
End price
25.12.21
€2.13
Summary
This prediction ended on 25.12.21 with a price of €2.13. The prediction for Oncternal Therapeutics Inc. disappointed with a performance of -18.44%. blaugold has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Oncternal Therapeutics Inc. | - | - | - |
iShares Core DAX® | -1.114% | 3.430% | 25.966% |
iShares Nasdaq 100 | 1.816% | 6.911% | 30.390% |
iShares Nikkei 225® | 2.113% | 5.501% | 23.404% |
iShares S&P 500 | 2.038% | 5.327% | 30.881% |
According to blaugold what are the pros and cons of Oncternal Therapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by blaugold for this prediction
In the thread Oncternal Therapeutics Inc. diskutieren
Buy Oncternal Therapeutics Inc.
In the thread Trading Oncternal Therapeutics Inc.
Buy beendet
Stopped prediction by blaugold for Oncternal Therapeutics Inc.
Oncternal Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.81
09.01.22
09.01.22
-
09.01.23
09.01.23
-12.41%
23.01.22
23.01.22
Could be very worthwhile Investment >20% year
Oncternal Therapeutics Inc.
Start price
Target price
Perf. (%)
€2.70
21.11.21
21.11.21
-
21.11.22
21.11.22
-4.30%
27.11.21
27.11.21
Could be very worthwhile Investment >20% year